Immunohistochemical study of Langerhans cells in cutaneous lesions of the Jorge Lobo's disease

Acta Tropica

Volumn 114, Issue 1, 2010, Pages 59-62

  Quaresma, Juarez Antonio Simoes ^a   Unger, Debora ^a   Pagliari, Carla ^b   Sotto, Mirian Nacagami ^b   Duarte, Maria Irma Seixas ^b   de Brito, Arival Cardoso ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dendritic cells; Immunology; Lacazia loboi; Lacaziosis

Indexed keywords

T6 ANTIGEN;

BIOCHEMISTRY; BIOLOGICAL ANALYSIS; FUNGAL DISEASE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNE SYSTEM; LESION; SKIN DISORDER;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; CELL COUNT; CELL POPULATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; LANGERHANS CELL; LOBOMYCOSIS; MALE; MYCOSIS; SKIN BIOPSY; SKIN DEFECT;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DERMATOMYCOSES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; MALE; MICROSCOPY; MIDDLE AGED; ONYGENALES; SKIN; SOUTH AMERICA;

FUNGI; LACAZIA LOBOI;

EID: 77249164146     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.12.005     Document Type: Article

References (24)

1. Aberer W., Schuler G., Stingl G., Honigsmann H., and Wolff K. Ultraviolet light depletes surface markers of Langerhans cells. J. Invest. Dermatol. 76 (1981) 202-210
2. Azadeh B., and Dabiri S. Langerhans cells in skin lesions of leprosy. Iran. J. Med. Sci. 29 (2004) 51-55
3. Cestari T.F., Kripke M.L., Baptista P.L., Bakos L., and Bucana C.D. Ultraviolet radiation decreases the granulomatous response to lepromin in humans. J. Invest. Dermatol. 105 (1995) 8-13
4. De Brito A.C., and Quaresma J.A.S. Lacaziosis (Jorge Lobo's disease): review and update. An. Bras. Dermatol. 82 (2007) 461-474
5. Hunger R.E., Sieling P.A., Ochoa M.T., Sugaya M., Burdick A.E., Rea T.H., Brennan P.J., Belisle J.T., Blauvelt A., Porcelli S.A., and Modlin R.L. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 113 (2004) 701-708
6. Kharkar V., Bhor U.H., Mahajan S., and Khopkar U. Type I lepra reaction presenting as immune reconstitution inflammatory syndrome. Indian J. Dermatol. Venereol. Leprol. 73 (2007) 253-256
7. Koch S., Kohl K., Klein E., von Bubnoff D., and Bieber T. Skin homing of Langerhans cell precursors: adhesion, chemotaxis, and migration. J. Allergy Clin. Immunol. 117 (2006) 163-168
8. Martin L.H., Calabi F., Lefebvre F.A., Bilsland C.A., and Milstein C. Structure and expression of the human thymocyte antigens CD1a, CD1b, and CD1c. Proc. Natl. Acad. Sci. 84 (1987) 9189-9190
9. Nestle F.O., and Nickoloff B.J. Dermal dendritic cells are important members of the skin immune system. Adv. Exp. Med. Biol. 378 (1995) 111-116
10. Pagliari C., and Sotto M.N. Dendritic cells and pattern of cytokines in paracoccidioidomycosis skin lesions. Am. J. Dermatopathol. 25 (2003) 107-112
11. Pecher S.A., and Funchs J. Cellular immunity in lobomycosis (keliodal blastomycosis). Allergol. Immunopathol. 16 (1988) 413-415
12. Pecher S.A. Deep mycoses in Latin America. Med. Trop. 54 (1994) 411-415
13. Rodriguez-Toro G. Lobomycosis. Int. J. Dermatol. 32 (1993) 324-332
14. Sieling P.A., Jullien D., Dahlem M., Tedder T.F., Rea T.H., Modlin R.L., and Porcelli S.A. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J. Immunol. 162 (1999) 1851-1858
15. Silva D., Macedo C., Oliveira C., and Unger D. Micose de Jorge Lobo simulando forma gomosa: um caso raro. An. Bras. Dermatol. 71 (1996) 211-213
16. Steinman R.M., and Germain R.N. Antigen presentation and related immunological aspects of HIV-1 vaccines. AIDS 12 Suppl. A (1998) S97-S112
17. Taborda P.R., Taborda V.A., and McGinnis M.R. Lacazia loboi gen. nov., comb. nov., the etiologic agent of lobomycosis. J. Clin. Microbiol. 37 (1999) 2031-2033
18. Vilani-Moreno F.R., Belone A.F., Soares C.T., and Opromolla D.V. Immunohistochemical characterization of the cellular infiltrate in Jorge Lobo's disease. Rev. Iberoam. Micol. 22 (2005) 44-49
19. Vilani-Moreno F.R., Lauris J.R., and Opromolla D.V. Cytokine quantification in the supernatant of mononuclear cell cultures and in blood serum from patients with Jorge Lobo's disease. Mycopathology 158 (2004) 17-24
20. Vilani-Moreno F.R., Silva L.M., and Opromolla D.V. Evaluation of the phagocytic activity of peripheral blood monocytes of patients with Jorge Lobo's disease. Rev. Soc. Bras. Med. Trop. 37 (2004) 165-168
21. Vilela R., Mendonza L., Rosa O.S., Belone A.F., Madeira S., Opromolla D.V., and de Resende M.A. Molecular model for studying the uncultivated fungal pathogen Lacazia loboi. J. Clin. Microbiol. 43 (2005) 3657-3661
22. Xavier M.B., Libonati R.M., Unger D., Oliveira C., Corbett C.E., de Brito A.C., and Quaresma J.A. Macrophage and TGF-beta immunohistochemical expression in Jorge Lobo's disease. Hum. Pathol. 39 (2008) 269-274
23. Yates S.F., Paterson A.M., Nolan K.F., Cobbold S.P., Saunders N.J., Waldmann H., and Fairchild P.J. Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J. Immunol. 179 (2007) 967-976
24. Zeng Z., Castaño A.R., Segelke B.W., Stura E.A., Peterson P.A., and Wilson I.A. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277 (1997) 339-345